News Image

Hoth Therapeutics Taps Lantern Pharma's PredictBBB.ai Platform -- Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development

Provided By PR Newswire

Last update: Sep 4, 2025

NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced that it is leveraging Lantern Pharma's breakthrough PredictBBB.ai™ platform, a next-generation artificial intelligence (AI) tool with 94% accuracy in predicting blood-brain barrier permeability. This adoption positions Hoth at the forefront of AI-driven drug development, reinforcing its commitment to cutting-edge innovation and accelerated therapeutic discovery.

Read more at prnewswire.com

HOTH THERAPEUTICS INC

NASDAQ:HOTH (10/24/2025, 8:00:01 PM)

Premarket: 1.36 -0.01 (-0.73%)

1.37

+0.01 (+0.74%)



Find more stocks in the Stock Screener

Follow ChartMill for more